Bioinformatical Assistance of Selecting Anti-HIV Therapies: Where Do We Stand?
Intervirology · 2012 · 55 (2) · 108-112
DOI: 10.1159/000332000 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Intervirology, online erschienen am 24.01.2012. Verfasst von Thomas Lengauer. Beteiligte Einrichtung: Max Planck Institute for Informatics, Saarbrücken, Germany. lengauer@mpi-inf.mpg.de. Hauptthemen laut MEDLINE: Drug Resistance, Viral. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
In this opinion statement, we give a critical synopsis of the state-of-the-art of bioinformatic HIV resistance analysis and point out what we consider to be challenges and perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Max Planck Institute for Informatics, Saarbrücken, Germany. lengauer@mpi-inf.mpg.de
Zitieren
APA
Lengauer, T. (2012). Bioinformatical Assistance of Selecting Anti-HIV Therapies: Where Do We Stand?. Intervirology, 55(2), 108-112. https://doi.org/10.1159/000332000
Vancouver
Lengauer T. Bioinformatical Assistance of Selecting Anti-HIV Therapies: Where Do We Stand?. Intervirology. 2012;55(2):108-112. doi:10.1159/000332000
BibTeX
@article{Lengauer2012,
author = {Lengauer, Thomas},
title = {Bioinformatical Assistance of Selecting Anti-HIV Therapies: Where Do We Stand?},
journal = {Intervirology},
year = {2012},
volume = {55},
number = {2},
pages = {108--112},
doi = {10.1159/000332000}
}
EUVIMED